Answers are grounded in this paper and cite their sources.
In 2023, ASCO updated its guideline on assessment and management of vulnerabilities in older patients undergoing chemotherapy.The update revisited recommendations from the previous guideline ( 2018), 1 in light of significant advances in the field since then and introduced an innovative geriatric assessment (GA) tool.][4] This companion Questions and Answers article addresses some concerns that clinicians experience as they implement the updated recommendations.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: